Welcome
Dr. Saifee Mullamitha is an experienced Consultant in Medical Oncology at The Christie NHS Foundation Trust, providing specialist cancer care since 2007. He completed his postgraduate training in Medical Oncology in the Northwest Deanery (UK) and brings overta two decades of experience, with a passionate and empathetic focus on the personalised management of both early and advanced colorectal cancer.
He has a special interest in liver-directed therapy, including Selective Internal Radiotherapy (SIRT) and chemo-saturation of the liver within the context of NHS clinical trials. Dr. Mullamitha is also a member of one of the UK's specialised peritoneal tumour MDTs, involved in the management of appendiceal malignancies and colorectal peritoneal metastasis, which entail cytoreductive surgery, HIPEC, and PIPAC (within NHS clinic trial context).
Actively engaged in clinical research, Dr. Mullamitha has served as the lead principal investigator in several national and international trials, including acting as the UK Chief Investigator in a recently completed immunotherapy trial for patients with advanced colorectal cancer.
Dr. Mullamitha is a Fellow of the Royal College of Physicians (RCP) and has held appointments such as Training Program Director for Northwest Medical Oncology, Junior Doctor Lead, and Chair of the Audit Committee at The Christie Hospital. He has also served as an examiner with the South Manchester University Hospitals (now MFT).
Dr. Mullamitha is committed to using the latest evidence-based treatments and maximising treatment opportunities - including immunotherapy and clinical trials - for patients for optimum survival, whilst also focussing crucially on the quality of life.
Services Offered
Services offered include advice and delivery of systemic chemotherapy, immunotherapy, liver directed therapy, second opinions, clinical trials and case reviews.
Selective Internal Radiotherapy (SIRT)
Selective Internal Radiotherapy (SIRT) is a highly targeted treatment used to treat cancer that has spread to the liver. It delivers radiation directly to cancer cells while minimising damage to healthy liver tissue. This approach can help control cancer growth, improve symptoms, and in some cases help patients live longer or become eligible for other treatments.
Learn More
Phase II/III NHS Clinical Trials in Colorectal Cancer
Dr. Saifee Mullamitha is actively involved in Phase II/III NHS clinical trials, helping patients access the latest treatments for colorectal cancer before they become more widely available. These studies play an important role in advancing cancer care and may offer additional treatment options for suitable patients.
Learn More
Rectal Cancer Treatment
Modern treatment of rectal cancer has advanced considerably, with a strong focus on tailoring care to each individual. I specialise in personalised treatment approaches, using strategies such as total neoadjuvant therapy (TNT), where chemotherapy and radiotherapy are given before surgery to improve outcomes and increase the chance of a good response.
Learn MorePatient Reviews
“Dr Mullamitha's air of calm authority inspires confidence in others. I have total confidence in his compassion and attention to detail.”
“Dr Mullamitha was amazing. He was so considerate, patient and really put me at ease. I felt very reassured and Dr Mullamitha kept in regular contact throughout. Definitely made the experience better than what I expected.”
“Dr Saifee Mullamitha is a very kind, helpful doctor who has helped me to seek the best care for my condition.”